Media

The article from Italy’s Quotidiano Nazionale features an interview with our CEO and co-founder Daniela Marino. She discusses our pioneering work in creating bioengineered skin on demand. Daniela highlights the benefits of this technology and our approach which allows us to generate large amounts of skin from a small patient’s own skin sample. More than 60 patients have been treated, among them also an infant. The article also covers CUTISS’s collaborations, including with the Buzzi Pediatric Hospital in Milan, the fundraising efforts, and the significant impact of our innovation on burn victims and reconstructive surgery. For more details, read the full article here. Newsroom Link to article

Tech.eu, the premier online publication dedicated to the growing European technology ecosystem, writes about CUTISS’s breakthrough with denovoSkin, a bioengineered skin graft designed to grow with patients, improving quality of life and significantly reducing the need for follow-up surgeries. The innovative skin graft is derived from a small piece of the patient’s healthy skin and can be produced in large quantities. This advancement offers hope for burn victims and those needing reconstructive surgery. The article also discusses CUTISS’s efforts in automation and our participation in advanced research initiatives, including in space, to enhance our understanding of skin regeneration. For more details, read the full article here. Newsroom Link to article

The Italian daily newspaper La Repubblica writes about our lead product denovoSkin™ being used to treat a child in Milan, Italy.  The young child suffered severe burns over a large portion of his body due to a domestic accident. Traditional skin grafts were not a viable option due to his young age and the extent of the injuries. This patient is now part of the ongoing pediatric clinical trial aimed at demonstrating the efficacy and safety of denovoSkin™ in young kids, who represent a particularly challenging demographic in burn surgery due to their delicate skin and rapid growth rates. A twin study in adolescents and adults has completed recruitment, and safety and efficacy has been recently demonstrated (read the press release here). A third study in reconstructive surgery has completed recruitment (read the press release here). In the article, Professor Gloria Pelizzo, who led the surgical team, noted the successful grafting of our personalized, bioengineered skin graft, highlighting the potential for denovoSkin™ to significantly improve outcomes in pediatric burn treatment. We extend a big thank you to Italian patients, surgeons and investors for being part of CUTISS’ journey. Newsroom Link to article

Discover CUTISS’s strides in developing the personalized skin tissue therapy denovoSkin™, as seen on TeleZüri’s CheckUp. The segment shares a patient’s remarkable recovery story, demonstrates how our pioneering skin graft technology can positively impact patients’ lives, and includes insights from CEO Dr. Daniela Marino. Watch the reportage to see the significant advancements denovoSkin™ brings to treating severe burns and enhancing patient outcomes. Newsroom Link to video reportage

The popular and influential Brazilian science magazine Superinteressante interviewed our CEO Daniela Marino about our development of denovoSkin™. The article describes the ways in which denovoSkin™ could revolutionize skin surgery and benefit patients worldwide. “We’re moving towards the last stage of development, and we hope to bring the technology to patients soon,” said Daniela in the interview. You can read the full article using the link below. Newsroom Link to article

We were excited to welcome Bloomberg television’s Hello World reporter and camera crew to our offices and manufacturing facility in Schlieren, Zurich. As part of their special feature into Switzerland’s most innovative tech startups, we had the opportunity to showcase our novel approach to skin surgery that promises to improve patient outcomes, and our vision for the future of tissue engineering.  Take a look at the reportage from within CUTISS’s headquarters, and hear what our CEO Daniela Marino says about shifting the paradigm in the treatment of severe burns. Newsroom Link to reportage

Genetic Engineering & Biotechnology News (GEN), the leading life sciences publication, recently interviewed our CEO Daniela Marino. The article reports on CUTISS’s progress with denovoSkin™ and the clinical trials, how the company plans to restore patients’ own skin pigmentation, the key role of automation to meet the scale up challenge, and CUTISS’s global ambitions. “The product we are developing really can replace autografting—the current standard-of-care treatment—not only for severe burns patients but also for other reconstructive surgeries,” said Daniela in the interview. You can read the full article using the link below. Newsroom Link to article

The leading industry media Fierce Biotech reported on the news that CUTISS sent human skin cells into space, for advanced R&D testing on the International Space Station. Our Chief Innovation Officer Vincent Ronfard explained in his interview the reasons for conducting such experiments and what we hope to achieve. The initial round of experiments will look at different dimensions of wound healing. One set of cultures contains wounded tissue, and we will focus on how long it takes a wound to close in microgravity. The second set will be used to study how extracellular matrix formation and collagen production differs between space and Earth. The projects will remain on the space station for four weeks before they’re returned. When asked what was it that provoked CUTISS to take this step into space-based research, Vincent replied: “There are two ways of research: One is very organized, but you’re always in the mainstream, and the other is that you’re opportunistic and you say, ‘Okay, let’s try’. When you don’t set too many boundaries, you may find new things that are important.” You can read the full article using the link below. Newsroom Link to article

Following our presence at Arab Health 2023 we had the opportunity to speak with BioVoice, the top Indian bioscience news magazine. In the interview, our CEO Daniela Marino shared the progress that CUTISS has been making in bioengineering the personalized skin graft denovoSkin, the commercial plans around skin pigmentation, and the exciting innovations in regenerative medicine. You can read the interview in the pdf below, or directly online here. Newsroom Interview (PDF)

CUTISS exhibited at the Arab Health 2023 expo in Dubai and had the opportunity to speak with Gulf Today. Our CEO Daniela Marino talked about how she got into the field, what made her decide to start a company, and the promising innovations that CUTISS is developing in skin tissue engineering, skin pigmentation, and regenerative medicine. The interview and article (“Human skin graft technology restores burn-damaged skin”) was published in a special print edition of Gulf Today. Newsroom Interview